BR9609691A - Composto processos para a preparação do mesmo e paraão tratamento de náuseas ou émese medicamento agente antiemético composição farmacéutica e uso do composto - Google Patents

Composto processos para a preparação do mesmo e paraão tratamento de náuseas ou émese medicamento agente antiemético composição farmacéutica e uso do composto

Info

Publication number
BR9609691A
BR9609691A BR9609691A BR9609691A BR9609691A BR 9609691 A BR9609691 A BR 9609691A BR 9609691 A BR9609691 A BR 9609691A BR 9609691 A BR9609691 A BR 9609691A BR 9609691 A BR9609691 A BR 9609691A
Authority
BR
Brazil
Prior art keywords
compound
nausea
preparation
pharmaceutical composition
stop treatment
Prior art date
Application number
BR9609691A
Other languages
English (en)
Inventor
Hiroshi Harada
Yoshimi Hirokawa
Naoyuki Yoshida
Shiro Kato
Toshiya Morie
Original Assignee
Dainippon Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co filed Critical Dainippon Pharmaceutical Co
Publication of BR9609691A publication Critical patent/BR9609691A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/08—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
BR9609691A 1995-07-28 1996-07-23 Composto processos para a preparação do mesmo e paraão tratamento de náuseas ou émese medicamento agente antiemético composição farmacéutica e uso do composto BR9609691A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP07212495 1995-07-28
PCT/JP1996/002053 WO1997005129A1 (fr) 1995-07-28 1996-07-23 (r)-5-bromo-n-(1-ethyl-4-methylhexahydro-1h-1,4-diazepin-6-yl)-2-methoxy-6-methylamino-3-pyridine-carboxamide, son procede d'obtention et medicament le contenant

Publications (1)

Publication Number Publication Date
BR9609691A true BR9609691A (pt) 1999-03-23

Family

ID=16623612

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9609691A BR9609691A (pt) 1995-07-28 1996-07-23 Composto processos para a preparação do mesmo e paraão tratamento de náuseas ou émese medicamento agente antiemético composição farmacéutica e uso do composto

Country Status (25)

Country Link
US (1) US5945415A (pt)
EP (1) EP0855397B1 (pt)
KR (1) KR19990028395A (pt)
CN (1) CN1096459C (pt)
AT (1) ATE201021T1 (pt)
AU (1) AU700635B2 (pt)
BR (1) BR9609691A (pt)
CA (1) CA2228056A1 (pt)
CZ (1) CZ290442B6 (pt)
DE (1) DE69612753T2 (pt)
DK (1) DK0855397T3 (pt)
ES (1) ES2156616T3 (pt)
GR (1) GR3036089T3 (pt)
HK (1) HK1018049A1 (pt)
HU (1) HUP9901208A3 (pt)
IL (1) IL122753A (pt)
MX (1) MX9800620A (pt)
NO (1) NO312964B1 (pt)
NZ (1) NZ312799A (pt)
PL (1) PL184073B1 (pt)
PT (1) PT855397E (pt)
RU (1) RU2156248C2 (pt)
SK (1) SK282044B6 (pt)
TR (1) TR199800165T1 (pt)
WO (1) WO1997005129A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19650778C2 (de) * 1996-12-06 2001-01-04 Asta Medica Ag Verwendung von Dopaminrezeptor-Antagonisten in der palliativen Tumortherapie
US20040048874A1 (en) * 2001-05-22 2004-03-11 Bardsley Hazel Judith New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine
GB0216027D0 (en) * 2002-07-10 2002-08-21 Arachnova Therapeutics Ltd New therapeutic use
ITBO20020198A1 (it) * 2002-04-12 2003-10-13 Univ Bologna Derivati 2 , 5 bis diammino 1 , 4 benzochenionici utili per il trattamento della malattia di alzheimer , metodo per la loro preparazione ed
PL378369A1 (pl) * 2003-01-13 2006-04-03 Dynogen Pharmaceuticals, Inc. Sposób leczenia mdłości, wymiotów, nudności lub ich dowolnej kombinacji
MXPA05007381A (es) * 2003-01-13 2006-02-10 Dynogen Pharmaceuticals Inc Metodo para el tratamiento de transtornos funcionales del intestino.
ES2290741T3 (es) * 2003-04-04 2008-02-16 Dynogen Pharmaceuticals Inc. Metodo de tratamiento de trastornos del tracto urinario inferior.
US20060293309A1 (en) * 2005-03-28 2006-12-28 Dynogen Pharmaceuticals, Inc. Method of treating disorders and conditions using peripherally-restricted antagonists and inhibitors
AU2010231439A1 (en) 2009-03-31 2011-10-27 Zeria Pharmaceutical Co., Ltd. Method for manufacturing 1,5-benzodiazepine derivative
JP5858917B2 (ja) 2010-08-26 2016-02-10 興和株式会社 イソキノリン誘導体又はその塩の新規製造方法
EP3102565B1 (en) * 2014-02-03 2019-01-02 Mylan Laboratories Ltd. Processes for the preparation of intermediates of raltegravir

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5017573A (en) * 1988-07-29 1991-05-21 Dainippon Pharmaceutical Co., Ltd. Indazole-3-carboxylic acid derivatives
US5166341A (en) * 1988-07-29 1992-11-24 Dainippon Pharmaceutical Co., Ltd. 6-amino-1,4-hexahydro-1H-diazepine derivatives
JPH04210970A (ja) * 1990-01-26 1992-08-03 Dainippon Pharmaceut Co Ltd ベンズアミド誘導体及びその中間体
JPH03223265A (ja) * 1990-01-26 1991-10-02 Dainippon Pharmaceut Co Ltd 環状ジアミン誘導体
PT100990A (pt) * 1991-10-24 1994-01-31 Smithkline Beecham Plc Derivados de piridina e sua utilizacao como substancia terapeutica

Also Published As

Publication number Publication date
GR3036089T3 (en) 2001-09-28
NZ312799A (en) 1999-04-29
RU2156248C2 (ru) 2000-09-20
EP0855397A1 (en) 1998-07-29
KR19990028395A (ko) 1999-04-15
HUP9901208A2 (hu) 2000-04-28
PL324749A1 (en) 1998-06-08
EP0855397B1 (en) 2001-05-09
CZ23098A3 (cs) 1998-06-17
US5945415A (en) 1999-08-31
DK0855397T3 (da) 2001-06-25
MX9800620A (es) 1998-04-30
CZ290442B6 (cs) 2002-07-17
AU6471796A (en) 1997-02-26
NO980333D0 (no) 1998-01-26
IL122753A (en) 2000-10-31
NO312964B1 (no) 2002-07-22
CN1096459C (zh) 2002-12-18
ATE201021T1 (de) 2001-05-15
CN1192213A (zh) 1998-09-02
CA2228056A1 (en) 1997-02-13
SK9398A3 (en) 1998-08-05
HUP9901208A3 (en) 2002-10-28
AU700635B2 (en) 1999-01-07
WO1997005129A1 (fr) 1997-02-13
PT855397E (pt) 2001-08-30
IL122753A0 (en) 1998-08-16
ES2156616T3 (es) 2001-07-01
PL184073B1 (pl) 2002-08-30
DE69612753T2 (de) 2005-07-07
SK282044B6 (sk) 2001-10-08
HK1018049A1 (en) 1999-12-10
NO980333L (no) 1998-03-23
EP0855397A4 (en) 1998-12-02
DE69612753D1 (de) 2001-06-13
TR199800165T1 (xx) 1998-06-22

Similar Documents

Publication Publication Date Title
AUPR213700A0 (en) Antiviral agents
DE69906518D1 (de) Arzneistoff-abgabesystem enthaltend eine festgepackte, feste arzneistoffbasis
SE9904508D0 (sv) New compounds
MY142551A (en) Substituted diaryl heterocycles, process for their preparation and their use as medicaments
WO2003048164A3 (en) Adenosine a2a receptor antagonists
BR9609691A (pt) Composto processos para a preparação do mesmo e paraão tratamento de náuseas ou émese medicamento agente antiemético composição farmacéutica e uso do composto
SE9901573D0 (sv) New compounds
DE50203456D1 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
ES2051834T3 (es) El uso de tetrahidrobenzeno(c,d)indol-6 carboxamidas para la preparacion de un medicamento para el tratamiento de la ansiedad.
DK1228758T3 (da) Anvendelse af sulfodehydroabietinsyre til behandling af inflammatorisk tarmsygdom
GR3019274T3 (en) Substituted 3-piperazinylalkyl-2,3-dihydro-4H-1,3-benzoxazine-4-ones, their preparation and their therapeutical use
AR005102A1 (es) Compuestos derivados de octahidro-pirrolo [1,2-a]-pirazina 2,7-sustituidos, composiciones farmaceuticas y uso de dichos compuestos para la fabricacion deun medicamento.
BR0214046A (pt) Derivados de pirazol como substâncias psicofarmacêuticas
SE9901572D0 (sv) New compounds
BRPI0409217A (pt) derivados e análogos antimicrobianos da [3.1.0]bicicloexilfeniloxazolidinona
NO175679C (no) Analogifremgangsmåte for fremstilling av en terapeutisk aktiv, substituert aminforbindelse
BR9917315A (pt) Composições medicinais para liberação imediata para uso oral
BRPI0413101A (pt) compostos de sulfonamida derivado de benzoxazinona, sua preparação e uso como medicamentos
NO20013480L (no) Legemiddel for torr hud
ATE270T1 (de) Neue n1-benzoyl-n2-phenyl-1,3-diaminopropan-2-ole und ihre salze; verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel.
NO20042881L (no) Substituerte cykloheksan-derivater
EP0979818A4 (en) BENZOIC ACID DERIVATIVES AND THEIR MEDICAL USE
KR930019626A (ko) 신규의 아세트아미드 유도체 및 그 용도
BR9805026A (pt) Compostos contdndo tetrahidrolipstatina

Legal Events

Date Code Title Description
FB36 Technical and formal requirements: requirement - article 36 of industrial property law
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements